| [1] |
Coudert B, Focan C, Genet D, et al. A randomized multicenterstudy of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EOＲTC trial 05971 [J]. Chronobiol Int, 2008, 25(5):680-696.
|
| [2] |
Mazzoccoli G, Piepoli A, Carella M, et al. Altered expression of the clock gene machinery in kidney cancer patients [J]. Biomed Pharmacotherapy, 2012, 66(3):175-179.
|
| [3] |
Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes [J]. Epidemiology, 2005, 16(2):254-258.
|
| [4] |
Relles D, Sendecki J, Chipitsyna G, et al. Circadian gene expression and clinicopathologic correlates in pancreatic cancer [J]. J Gastrointest Surg, 2013, 17(3):443-450.
|
| [5] |
Mazzoccoli G, Panza A, Valvano M R, et al. Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients [J]. Chronobiol Int, 2011, 28(10):841-851.
|
| [6] |
Kusanagi H, Hida A, Satoh K, et al. Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells [J]. Neurosci Res, 2008, 61(2):136-142.
|
| [7] |
邓香群, 刘保安. 生物钟基因Clock/Bmal1表达与结肠肿瘤发生发展关系的研究[D]. 湖南: 中南大学, 2009: 1-18.
|
| [8] |
Yaping W, Luchun, H. Chao L,et al. Expression of circadian Period2, hPer2, in human colorectal carcinoma [J]. World Journal of Surgical Oncology, 2011, (9):166.
|
| [9] |
Krugluger W, Brandstaetter A, Kállay E, etal. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors [J]. Cancer Res, 2007, 67(16):7917-7922.
|
| [10] |
陈海霞，金风，吴伟莉, 等.鼻咽癌时间调节化疗诱导加同期调强放疗的疗效分析 [J].中华放射医学与防护杂志, 2012, 32(5):48-51.
|
| [11] |
李媛媛，金风，吴伟莉, 等. 时辰诱导化疗序贯同步放化疗治疗局部晚期鼻咽癌的Ⅱ期临床研究[J].中国肿瘤临床, 2013, 40(15):34-39.
|
| [12] |
蒋华，姜维美，刘燕文. 时辰化疗与肿瘤患者生活质量关系的研究 [J]. 中华肿瘤防治杂志, 2008, 5(9):699-702.
|
| [13] |
Kusanagi H,Hida A,Satoh K,et al. Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells [J]. Neurosci Res, 2008, 61(2):136-142.
|
| [14] |
Gorbacheva VY, Kondrotov RV, Zhang R, et al. Cireadian senstivity to the chemotherapeutic agent cyclophosphamid depends on the function status of the CLOCK/BMAL1 transactiviation complex [J]. Proc Natl Acad Sci USA, 2005,102(9):3407-3412.
|
| [15] |
Watara S, Seiichi T. Overexression of both Clock and Bmal1 inhibits entry to S phase in human colon cancer cells [J]. Fukushima J. Med Sci, 2015, 61(2):111-124.
|
| [16] |
Blask DE, Sauer LA, Dauchy RT. Melaton in asachronobiotician/anticancer agegnt, Cellular, biochemical and molecular mechanisms of actiong and their implications for circadian based cancer therapy [J]. Curr Top Med Chem, 2002, 2(2):113-132.
|
| [17] |
Bernard S, Cajavec Bernard B, Lévi F, et al. Tumor growth rate determines the timing of optimal chronomodulated treatment schedules [J]. PLOS Comput Biol, 2010, 6(3):e1000712.
|
| [18] |
曾佳，黄婷，王志, 等. 基于时辰治疗学的给药技术研究进展 [J].中国新药杂志, 2012, 8(8):873-878.
|
| [19] |
史玉树.局部晚期非小细胞肺癌时辰放疗的临床研究 [J].中国实用医药, 2012, 7(26):100-101.
|